Le Lézard
Classified in: Health
Subjects: MAV, CPG, CFG

/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Friday, March 1, 2024/


OTTAWA, ON, Feb. 29, 2024 /CNW/ -

Note: All times local

Northern Ontario


11:30 a.m.     

The Prime Minister will highlight the recently signed Canada-Ontario health care agreement. A media scrum will follow.




Notes for media:


  • Open coverage 
  • Media are asked to arrive no later than 10:45 a.m.
  • Media interested in participating can contact [email protected] for details.

2:10 p.m.       

The Prime Minister will meet with a local community group. 




Note for media:


  • Pooled photo opportunity

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 12:12
The Trade and Investment Promotion Agency of Costa Rica (PROCOMER) will bring together investors from around the world in San José, as part of the first edition of the FDI Summit, which will take place between June 11 and 12, at the Convention...

at 12:10
(Family Features) People with outward appearances of success, productivity and happiness often still deal with internal struggles. Mental health challenges continue to affect Americans, with nearly 3 of 4 (73%) U.S. adults reporting struggles with...

at 12:05
Sunnybrook Dentistry & Braces is proud to announce it will join parent company, Benevis, a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, for its ninth annual Sharing...

at 12:05
RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced that the Food and Drug Administration...

at 12:02
Last month a new utility patent, US Patent 11,953,501, was issued to LSU Health New Orleans for a noninvasive test called NECDetect that aids in early detection of necrotizing enterocolitis (NEC), a potentially fatal condition in premature infants....

at 12:00
CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team. David DiGiusto, Ph.D., joins as Technical, Scientific, and...



News published on and distributed by: